Marjorie Green
Fortuna: 241 581 $ al 31/05/2026
Fortuna: 241 581 $ al 31/05/2026
Dr. Marjorie C.
Green, MD, is an Independent Director at NeoGenomics, Inc. and a SVP, Head-Oncology & Global Clinical Development at Merck & Co., Inc. She is on the Board of Directors at NeoGenomics, Inc. She received her undergraduate degree from the University of Notre Dame and a doctorate degree from the University of Texas Medical Branch.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NEOGENOMICS, INC. 0,02 % | 01/06/2026 | 22.964 ( 0,02 % ) | 241 581 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MERCK & CO., INC. | Director Técnico/Científico/I+D | - |
| NEOGENOMICS, INC. | Director/Miembro de la Junta | 19/06/2025 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
NeoGenomics, Inc.
NeoGenomics, Inc. Medical/Nursing ServicesHealth Services Provides genetic and molecular testing services | Health Services |
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Texas Medical Branch
University of Texas Medical Branch Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.